Triad Isotopes Buys Radiopharmacies from Covidien

Covidien (NYSE: COV) has sold its U.S. radiopharmacy network to Triad Isotopes Inc., an Orlando, Fla.-based provider of radiopharmaceuticals that are used for both diagnostic imaging procedures and disease treatment. No financial terms were disclosed. Triad Isotopes is a portfolio company of Parthenon Capital.

DealsNorth AmericaUSBriefs